ObsEva's uterine fibroids drug linzagolix has hit a snag at the FDA, portending a likely delayed regulatory decision. Rather than stick it out and see if its small molecule can match up against commercialized products from AbbVie and Myovant, ObsEva plans to give up rights to the drug as part of a corporate restructuring.
Currently, according to Tufts researchers, clinical trials in a variety of therapeutic areas experience patient dropout rates close to 20%, with the consent process being the number 1 factor contributing to this figure.
It is critical that the consent process be tailored to ensure that participants understand what's being asked of them and how their data will help further future disease treatment. The Solution: eConsent
Don't miss out on this valuable opportunity to meet and discuss the latest trends and opportunities. This is your chance to save $100 with the Early Bird Rate.
Decentralized clinical trials, drug discovery technologies, and partnering strategies between big pharma and startups were among the topics covered during INVEST PharmaTech, a virtual event hosted this week by MedCity News.
By Marissa Plescia Wednesday, July 27, 2022 7:57 PM
Mayo experts work with the companies to understand AI model requirements, check for fairness and bias in their AI models, help them understand the Food and Drug Administration clearance process and more.
By Stephanie Baum Wednesday, July 27, 2022 6:35 PM
A panel discussion on the future of digital medicine highlighted some of the collaborations taking place between pharma companies and digital health, as well as some of the challenges facing the push towards mainstream implementation.
High levels of clinical intervention for the most at-risk patients is not needed for many of the people living in nursing homes, but a more intermediate combination of continuous monitoring, appropriate home visits, and out-patient visits would have a positive impact upon their lives, health, and the overall cost of care.
Hospitals and health systems should consider implementing automated patient engagement technology that supports functions individuals value most—those that directly impact their ability to seek and receive healthcare.
Funding in FemTech startups has risen from next to nothing in 2008, to almost $2.5 billion in 2021; deals have seen the same trend, from a handful to almost 300 over the same period.
Replace the tedious manual resume screening process! Learn how AI frameworks and technology are streamlining the recruiter/candidate experience, resulting in healthcare industries hiring skilled and knowledgeable personnel quickly and effectively.
-Recovered.png?width=1200&height=400&upscale=true&name=DIgital%20Health%20Header(1)-Recovered.png)
No comments